Hishida S, Kawakami K, Fujita Y, Kato T, et al. Proteomic analysis of extracellular vesicles identified PI3K pathway as a potential therapeutic target for cabazitaxel-resistant prostate cancer. Prostate 2021 Apr 27. doi: 10.1002/pros.24138.
PMID: 33905554